AI
ABBVIE INC
ABBV· Health Care· BiotechnologyS&P 500
Close · 12/10/2026
281.12
1D
+1.68%52-week range
190.75 – 281.3
Volume
55,93,700.00
Price history
ABBV
11/09/2026 to 12/10/2026
O 277.65 H 281.30 L 276.01
1W+5.78%
1M+9.33%
3M+14.85%
6M+36.16%
1Y+21.86%
3Y+90.65%
5Y+158.55%
MAX+146.47%
Fundamentals
as of 12/10/2026- Market cap
- $496.77B
- Shares out
- 1.77B
- P/E (trailing)
- 78.73
- P/E (forward)
- 17.01
- EPS (trailing)
- 3.57
- Dividend yield
- 2.43%
- Beta
- 0.23
- Profit margin
- 9.80%
- P/B
- -82.31
SEC financial statements
58 quarterly and 15 annual periods through 30/06/2026.
Details
- Ticker
- ABBV
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 12/10/2026.
Tracked by Congress
26 filers · 2 on watchlist · 42 buys · 41 sells · 1 option · ?: 11 · D: 41 · R: 31
- 14/09/2026Pete SessionsSellAbbVie Inc. Common Stock$15,001–$50,000
- 27/03/2026Alan ArmstrongBuyAbbVie Inc. Common Stock$15,001–$50,000
- 05/05/2026Josh GottheimerWSellAbbVie Inc. Common Stock$1,001–$15,000
- 18/12/2025Julie JohnsonSellAbbVie Inc. Common Stock$1,001–$15,000
- 08/12/2025Julia LetlowSellAbbVie Inc. Common Stock$1,001–$15,000
- 28/04/2025Julia LetlowBuyAbbVie Inc. Common Stock$1,001–$15,000
- 24/01/2025Julia LetlowSellAbbVie Inc. Common Stock$1,001–$15,000
- 23/10/2024Julia LetlowBuyAbbVie Inc. Common Stock$1,001–$15,000